ALKS Shares Outstanding History
Below is a table of the ALKS shares outstanding history going back to 2/1/2010:

Date ALKS Shares Outstanding
2/1/201094.44M
5/13/201094.88M
8/3/201095.11M
11/1/201095.23M
1/31/201195.34M
5/13/201195.73M
7/12/201197.56M
7/25/201197.61M
11/1/2011129.59M
1/30/2012129.74M
5/11/2012130.24M
7/20/2012130.86M
10/26/2012131.93M
1/28/2013133.17M
5/8/2013134.38M
7/22/2013135.69M
10/28/2013136.76M
2/13/2014144.19M
4/24/2014144.52M
7/25/2014145.83M
10/24/2014146.23M
2/12/2015148.07M
4/24/2015148.63M
7/27/2015149.40M
10/26/2015150.06M
2/12/2016150.74M
4/22/2016151.17M
7/22/2016151.56M
10/24/2016151.97M
2/13/2017152.55M
4/24/2017153.19M
7/21/2017153.66M
10/23/2017153.78M
2/2/2018156.14M
4/20/2018155.04M
7/23/2018155.32M
10/19/2018155.38M
2/4/2019156.04M
4/22/2019156.90M
7/22/2019157.13M
10/18/2019157.52M
2/4/2020157.79M
4/24/2020158.74M
7/24/2020159.04M
10/23/2020159.15M
2/5/2021159.24M
4/23/2021160.45M

Also see: ALKS Market Cap History
ALKS YTD Return
ALKS Historical Shares Outstanding:
+4.83% CAGR
ALKS Historical Shares Outstanding: +4.83% CAGR

Mouse over chart for data details
2/1/2010 ...4/23/2021
Alkermes is a biopharmaceutical company. Co. has a portfolio of marketed products focused on central nervous system disorders such as addiction and schizophrenia and a pipeline of product candidates in the fields of neuroscience and oncology. Co.'s proprietary products include: ARISTADA, which is an extended-release intramuscular injectable suspension approved in the United States for the treatment of schizophrenia; ARISTADA INITIO, which is indicated for the initiation of ARISTADA when used for the treatment of schizophrenia in adults; and VIVITROL, which is for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification. We show 47 historical shares outstanding datapoints in our coverage of ALKS's shares outstanding history.

Understanding the changing numbers of ALKS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ALKS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ALKS by allowing them to research ALKS shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ALKS:
ALKS SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Alkermes (ALKS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ALNA Shares Outstanding History
ALNY Shares Outstanding History
ALOG Shares Outstanding History
ALPN Shares Outstanding History
ALQA Shares Outstanding History
ALRN Shares Outstanding History
ALT Shares Outstanding History
ALXN Shares Outstanding History
AMAG Shares Outstanding History
AMDA Shares Outstanding History
More Healthcare companies »

 

ALKS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.